Josefina Adolfsson

Learn More
The presence of high-grade prostatic intraepithelial neoplasia (PIN) in a prostate biopsy is a considerable risk factor for the presence of prostate cancer, with up to 73% of patients having cancer on rebiopsy. The risk is related to the clinical setting (screening vs urological practice) and patient factors such as prostatic serum antigen (PSA) and(More)
The effect of diet on the occurrence of canine atopic dermatitis (CAD) in the high-risk breeds boxer, English bull terrier and West Highland white terrier was investigated as part of an extensive case-control study. In that study, a sparing association was seen for feeding the bitch a diet containing non-commercial ingredients during lactation and the(More)
An attempt was made to see if new forms of treatment of fungal and bacterial septicemia, or new cytostatic combinations have changed the causes of death in leukemia and lymphoma. Autopsies were studied of 16 cases with acute leukemia, 2 with chronic granulocytic leukemia and 24 with lymphoma. 10 of the 18 patients with leukemia and 10/14 lymphoma patients(More)
OBJECTIVES To evaluate the concept of active monitoring only in the management of patients with prostate cancer. METHODS Literature review. RESULTS Active monitoring may be recommended in patients with stage T1a, well- and moderately-differentiated disease. Patients with a life expectancy exceeding 10 years are recommended re-evaluation with PSA, TRUS(More)
Improvements in the management of prostate cancer have increased the need to consider patients' quality of life, in particular in relation to sexual function. The causes of sexual dysfunction are varied and derive from both the condition and its management. Health professionals must choose their treatment strategies with great care. Patient expectations(More)
The best approximation of the natural course of early prostate cancer comes from studies on deferred treatment. In such studies, the 10-year disease-specific survival rate is 85-90% for patients with clinically localized tumours and 74% for those with tumours not confined to the prostate gland; 15-year data are sparse and diverging. Patients with poorly(More)
OBJECTIVE To describe and evaluate treatment alternatives for patients with clinical T3 prostate cancer. MATERIAL AND METHODS Literature review with main focus on recent studies in order to include the impact of prostate specific antigen (PSA). The possibility of using neoadjuvant/adjuvant hormonal therapy in combination with surgery or radiation was(More)